Secundum defects are the most common type of ASDs, and occur twice as often in females compared to males. 2 They classically involve the middle portion of the IAS but can occur in other areas of the IAS and result from either excessive absorption of the septum primum or arrested growth of the septum secundum. Two-dimensional echocardiography (2DE) is adequate in detecting these defects, but the images obtained can lack the detail necessary to precisely measure their size, shape, and location. This is most pronounced when assessing the multiple holes or Swiss cheese pattern, in which these limitations become more evident. Three-dimensional transthoracic echocardiography (TTE) performed via the apical, para-apical, right parasternal and subcostal views provide enhanced visualization of the defect in the majority of patients (Fig 1) . Furthermore, 3D TTE has been shown to better approximate the dimensions and locations of ASDs as well as the adjoining anatomy and rim size as compared to 2D images. 3, 4 In one study, Morgan et al. compared parameters obtained from 2D transesophageal echocardiography (TEE) to 3D TTE. Although the differences in measuring the defect's circumference, area, and diameter was not statistically significant when comparing the two imaging studies, it was clinically significant, showing that 3D TTE was just as accurate in its ability to recognize appropriate candidates for percutaneous closure of ASDs, there by reducing the need for the more invasive TEE procedure and bypassing its major complications such as gastrointestinal bleeding, esophageal hematoma formation, and perforation. 5
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Incremental Value of Three-Dimensional Echocardiography over Two-Dimensional Echocardiography in the Assessment of Atrial Septal Defects
Most ASDs, including the secundum type, have historically been repaired via median sternotomy, though advancements in technology have made percutaneous closure the current treatment of choice in the majority of patients. This decision is based on the specifications of the defect, including its size, shape, and location in space compared to the surrounding tissues. 3, 6 Percutaneous transthoracic repair can be done if the rim size is greater than 5 mm. Thus, it is important to correctly obtain a complete image of the defect in order to ascertain its eligibility for the less invasive procedure. The ability of 3D TTE to approximate measurements precisely not only helps when planning the transcatheter approach to the procedure, 3, 7 but also provides important data required to select the appropriate size of the occluder device which is crucial. Selecting a poorly fitting occluder device can lead to major complications, including breakdown of the device, persistence of the shunt, device embolization, and even perforation of the heart. 8 Additionally, 3D TTE has also been shown to help in detecting the above-mentioned complications, allowing for immediate recognition and reversal of the complication, leading to speedy repair and recovery. Sinus venosus ASDs (SVASD) are uncommon and form only 5% as opposed to secondum defects which comprise 75% of all ASDs. These defects are noted by echocardiography at the junction of the SVC, or rarely IVC, with the IAS. Unlike TEE, they are difficult to diagnose by TTE in an adult because the region of SVC entrance into the RA is not generally imaged during a routine 2D echo study. Therefore, non-standard approaches such as the right parasternal window are used to detect them. While both 2D and 3D echocardiography have been shown to be effective in detecting SVASDs, the latter has proven to be advantageous. 3D TEE can correctly visualize the defect in relation to the SVC and the anomalously draining right superior pulmonary vein while 2D imaging has been inferior in this regard (Fig 3) and can also calculate the area of SVASDs due to the added dimensions gained from the 3D rendered image. 14 Briefly, PFOs typically occur, as mentioned previously, through separation of the septum primum from the septum secondum due to elevated RA pressure, forming a shunt. A specific diagnosis can be made if a saline bubble study during the Valsalva maneuver, straining or abdominal pressure (more convenient during TEE) shows bulging of the IAS into the LA with micro bubbles crossing the PFO region from the RA into the LA. Transient bulging of the IAS into the LA suggests that the maneuver was successful in raising the RA pressure higher than the LA pressure. Thus, a PFO can be missed, but also cannot be excluded in the absence of IAS bulging. PFOs may be better diagnosed by 2D TEE as compared to 2D TTE because of its superior image quality. A PFO can also be missed during TTE or TEE unless there is a good contrast effect with complete filling of the RA. But 3D TEE may supplement 2D TEE by enabling a more detailed description of the complete PFO anatomy and surrounding tissues to a potentially higher degree of certainty, which can be helpful in differentiating intracardiac from extracardiac shunts. 15
In conclusion, echocardiography has been crucial as a diagnostic tool for all forms of CHD, including ASDs. Once the diagnosis is clear, imaging further helps delineate the best treatment option. While 2DE is still recommended by current guidelines as the gold standard, it is evident that 3DE can provide valuable supplemental information. The major advantages of 3DE over 2DE are en face views of the defects with clear delineation of rim tissue as well as the surrounding structures and more accurate measurements of defect dimensions and areas. 16 In addition, since the 3D data set containing the defect and the surrounding structures can be stored in a convenient medium such as a compact disc or an external drive, it can be re-cropped and sectioned in any desired manner. These findings can then be reviewed again for accuracy by either the same or different observers at any time, which is not possible with 2DE.As the technology develops further and becomes more widespread, 3DE use will potentially lead to better discovery of anomalies, reduction in repair complications rates, and ultimately enhanced patient care. Fig.-3 a,b, 
